In the Washington Post article “How Jimmy Carter boosted a life-saving cancer drug,” our scientific advisor Dr. Drew Pardoll provides his outlook on Carter’s impact on immune therapy. Pardoll, the director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins says, “For the public, Carter put immunotherapy on the map, period. Patients started asking for it. It was called “the Jimmy Carter effect.” Click here to read more: http://ow.ly/l4xr50Nh9zW #immunotherapy
